US Drug Recall Register
Class II · Moderate risk Terminated Initiated Mar 15, 2022 (4 years ago)

Diflorasone Diacetate Ointment USP

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

cGMP deviations: all products within expiry are being recalled because the firm is discontinuing its stability study program.

What was recalled

Diflorasone Diacetate Ointment USP, 0.05%, Net Wt 60 g tubes, Rx only, Manufactured by: Teligent Pharm, Inc., Buena, New Jersey 08310, NDC 52565-063-60.

Recalling firm
Teligent Pharma, Inc.
NDC code
52565-063-60
Origin
NJ, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0701-2022

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Diflorasone recalls

See all
Class III · Low risk Ongoing

Diflorasone Diacetate Ointment

Reason Failed Impurities/Degradation Specifications: The impurity results at 12 months stability testing,did not conform to the specification limit.

Rising Pharma Holding, Inc. NDC 64980-124-60 D-0599-2024
Class II · Moderate risk Terminated

Diflorasone Diacetate Ointment USP

Reason cGMP deviations: all products within expiry are being recalled because the firm is discontinuing its stability study program.

Teligent Pharma, Inc. NDC 70512-031-60 D-0681-2022
Class II · Moderate risk Terminated

Diflorasone Diacetate Ointment USP

Reason Presence of Foreign Substance: Foreign particles observed during routine stability testing.

Teligent Pharma, Inc. NDC 52565-063-15 D-0636-2021